0
0.5
1
1.5
2+
Mortality
18%
Improvement
Relative Risk
Ventilation
-19%
Ongoing hospitalization..
-17%
primary
Hospitalization time
-20%
Degarelix HITCH LATE TREATMENT DB RCT
Is late treatment with antiandrogens beneficial for COVID-19?
Double-blind RCT 96 patients in the USA (July 2020 - April 2021)
Trial underpowered for serious outcomes
c19early.org
Nickols et al., JAMA Network Open, Apr 2022
Favors degarelix
Favors control